AMRN Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -8.68%, SMA50 -16.84%, SMA200 -1.53%). The stock’s 14-day RSI is 32.23 (weak momentum), while the ATR of 0.76 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -33.97% below its high and over 94.92% above its low. Average 10-day trading volume of 94.33 thousand shares is below the 3-month average of 110.61 thousand, indicating normal recent market interest.

Amarin Corporation plc (NASDAQ:AMRN) closed at $13.87 USD, gaining $0.06 (0.47%) from the previous close of $13.80. The stock is currently mid-range between its 52-week high and low $7.00 and $20.90. With a market capitalization of about $286.77 million, Amarin Corporation plc is classified as a micro-cap and shows lower-than-market volatility (beta ~0.71). Key stats such as the average daily volume over the past year has been around 111.38 thousand shares, volume is running light vs its 52-week average. Headquartered in Dublin, None, Amarin Corporation plc operates in the Healthcare sector and the Biotechnology industry. Led by CEO Aaron D. Berg, the company employs approximately 275 people and listed since April 01, 1993. Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates.

Amarin Corporation plc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.27. This means the shares are trading below this model’s fair value.

Amarin Corporation plc has 20.79 million shares outstanding. The public float is 375.85 million shares, elevated short interest at 2.91% of float. This equals 416.19 thousand shares. The short ratio is 3.91 days. Institutional investors hold 18.39% of the float. Insiders own 1.88%. THERO JOHN F holds 2.74 million shares, Berg Aaron has 805.38 thousand shares and Ketchum Steven B has 566.10 thousand shares.

Amarin Corporation plc generated EPS of -$4.17 over the past year. Five-year average earnings growth is -24.69%. Wall Street analysts project EPS growth of 76.88% annually over the next five years. The latest quarter delivered EPS of -$0.02. The next quarter is forecast at $0.03. Next year's EPS is expected at $4.51. Analyst sentiment is bearish. Analyst rating data shows there are 0 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 1 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $12.00. The high target offers -13.04% upside. The low target suggests -13.04% downside. The mean target is $12.00. This offers -13.04% upside. Amarin Corporation plc earnings surprise history is a mixed track record. The quarter that ended October 29, 2025, missed forecasts by -123.28%. The prior quarter beat by -95.45%. Over the last six quarters, Apple has recorded several small beats. These include -120.72% in July 31, 2024.

Our AI price prediction model suggests that Amarin Corporation plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -14.2%, with price expected at $11.84 by January 02, 2026, within a range of $11.33 to $12.33 3-Month Outlook: Projected fall of -4.28%, reaching $13.21 by March 19, 2026, with a range of $12.41 to $13.95. 1-Year Outlook: Projected gain of 157.75%, with price at $35.57 by December 18, 2026, within a range of $27.14 to $47.79.

Amarin Corporation plc (NASDAQ:AMRN) shares are up 42.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Amarin Corporation plc trading at a premium to the broader market with a P/E of -66.4. Analyst sentiment is cautious, with the majority of ratings in Sell territory and a mean price target of $12.96, suggesting -6.09% downside. Our AI forecast model points to short-term weakness (-14.2% over two weeks), a medium-term fall (-4.28% over three months), and a longer-term gain (157.75% over one year), with expected trading ranges indicating moderate volatility.

Amarin Corporation plc trades at a P/E ratio of -66.4, slightly below the S&P 500 average, with a price-to-sales ratio of 1.43 and a price-to-book ratio of 12.5 reflecting a rich premium to book value. The P/FCF stands at -13.06, also below market averages. Compared to sector medians, Amarin Corporation plc P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.